Faster activation of polymorphonuclear neutrophils in resistant mice during early innate response to Pseudomonas aeruginosa lung infection

Clinical and Experimental Immunology

Volumn 137, Issue 3, 2004, Pages 478-485

  Jensen, P O ^a,b   Moser, C ^a   Kobayashi, O ^a   Hougen, H P ^a   Kharazmi, A ^a   Hoiby N ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Rigshospitalet   (Denmark)

Author keywords

P. aeruginosa; PMN response; Pneumonia

Indexed keywords

CD11B ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR; MACROPHAGE INFLAMMATORY PROTEIN 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD; BONE MARROW; CHEMOTAXIS; CYSTIC FIBROSIS; FEMALE; LUNG; LUNG INFECTION; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SYSTEMATIC REVIEW;

ANIMALS; ANTIGENS, CD11B; BRONCHOALVEOLAR LAVAGE FLUID; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; IMMUNITY, NATURAL; L-SELECTIN; LEUKOCYTE COUNT; LUNG; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MONOKINES; NEUTROPHIL ACTIVATION; NEUTROPHILS; PSEUDOMONAS INFECTIONS;

EID: 4344580534     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2004.02554.x     Document Type: Article

References (65)

1. Riordan JR, Rommens JM, Kerem BS et al. Identification of the cystic fibrosis gene: cloning and characterisation of complementary DNA. Science 1989; 245:1066-73.
2. Armstrong D, Grimwood K, Carlin JB et al Lower airway inflammation in infants and young children with cystic fibrosis. Am J Resp Crit Care Med 1997; 156:1197-204.
3. Koch C, Høiby N. Pathogenisis of cystic fibrosis. Lancet 1993; 341:1065-9.
4. Doggett RG, Harrison GM, Stillwell RN, Wallis ES. An atypical Pseudomonas aeruginosa associated with cystic fibrosis of the pancreas. J Pediatr 1966; 68:215-20.
5. Høiby N. Pseudomonas aeruginosa infection in cystic fibrosis. Relationship between mucoid strains of Pseudomonas aeruginosa and the humoral response. Acta Pathol Microbiol Scand B 1974; 82:551-8.
6. Jensen ET, Kharazmi A, Lam K, Costerton JW, Høiby N. Human polymorphonuclear leukocyte response to Pseudomonas aeruginosa grown in biofilm. Infect Immun 1990; 36:2383-5.
7. Mathee K, Ciofu O, Sternberg C et al. Mucoid conversion of Pseudomonas aeruginosa by hydrogen peroxide: a mechanism for virulence activation in the cystic fibrosis lung. Microbiology 1999; 145:1349-57.
8. Anwar H, Strap JL, Costerton JW. Susceptibility of biofilm cells of Pseudomonas aeruginosa to bactericidal actions of whole blood and serum. FEMS Microbiol Lett 1992; 92:235-42.
9. Govan JRW, Fyfe JAM. Mucoid Pseudomonas aeruginosa and cystic fibrosis. Resistance of the mucoid form to carbenicillin, flucloxacillin and tobramycin and the isolation of mucoid variants in vitro. J Antimicrob Chemother 1978; 4:233-40.
10. Standiford TJ, Kunkel SL, Greenberger MJ, Laichalk LL, Strieter RM. Expression and regulation of chemokines in bacterial pneumonia. J Leuk Biol 1996; 59:24-8.
11. Cuthbert A. Cystic fibrosis gene update. J Roy Soc Med 1994; 87:2-4.
12. Høiby N. Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed immuneelectrophoresis: a survey. Acta Path Microbiol Scand Sect C Suppl 1977; 262:3-96.
13. Gosselin D, Desanctis J, Boule M, Skamane E, Matouk C, Radzioch D. Role of tumor necrosis factor alpha in innate resitance to mouse pulmonary infection with Pseudomonas aeruginosa. Infect Immun 1995; 63:3272-8.
14. Pedersen SS, Shand GH, Hansen BL, Hansen GN. Induction of experimental chronic Pseudomonas aeruginosa lung infection with P. aeruginosa entrapped in alginate microsphere. APMIS 1990; 98:203-11.
15. Moser C, Johansen HK, Song Z, Hougen HP, Rygaard J, Høiby N. Chronic Pseudomonas aeruginosa lung infection is more severe in Th2 responding BALB/c mice compared to Th1 responding C3H/HeN mice. APMIS 1997; 105:838-42.
16. Moser C, Hougen HP, Song Z, Rygeard J, Kharazmi A, Høiby N. Early immune response in susceptible and resistant mice with chronic Pseudomonas aeruginosa lung infection determines the type of T-helper cell response. APMIS 1999; 107:1093-100.
17. Moser C, Kjaergaard S, Pressler T, Kharazmi A, Koch C, Høiby N. The immune response to chronic Pseudomonas aeruginosa lung infection in cystic fibrosis patients is predominantly of the Th2 type. APMIS 2000; 108:329-35.
18. Driscoll KE. Macrophage inflammatory proteins: biology and role in pulmonary inflammation. Lung Res 1994; 20:473-90.
19. Saukkonen K, Sande S, Cioffe C et al. The role of cytokines in the generation of inflammation and tissue damage in experimental Gram positive meningitis. J Exp Med 1990; 171:439-48.
20. Verhoef G, Boogaerts M. Treatment with granulocyte-macrophage factor and the adult respiratory distress syndrome. Am J Hematol 1991; 66:285-7.
21. Frevert CW, Farone A, Danaee H, Paulauskis JD, Kobzik L. Functional characterization of rat chemokine macrophage inflammatory protein-2. Inflammation 1995; 19:133-42.
22. Brown E. Neutrophil adhesion and the therapy of inflammation. Semin Hematol 1997; 34:319-26.
23. Metcalff D, Robb L, Dunn AR, Mifsud S, Rago LD. Role of granulocyte-macrophage colony stimulating factor and granulocyte-colony stimulating factor in the development of an acute neutrophil inflammatory response in mice. Blood 1996; 88:3755-64.
24. Johansen HK, Espersen F, Pedersen SS, Hougen HP, Rygaard J, Høiby N. Chronic Pseudomonas aeruginosa lung infection in normal and athymic rats. APMIS 1993; 161:207-25.
25. Cheung DO, Halsey K, Speert DP. Role of pulmonary alveolar macrophages in defense of the lung against Pseudomonas aeruginosa. Infect Immun 2000; 68:4585-92.
26. Morissette C, Francoeur C, Darmond-Zwaig C, Gervais F. Lung phagocyte bactericidal function in strains of mice resistant and susceptible to Pseudomonas aeruginosa. Infect Immun 1996; 64:4984-92.
27. Moser C, Jensen PO, Kobayashi O et al. Improved outcome of chronic Pseudomonas aeruginosa lung infection is associated with induction of a Th1-dominated cytokine response. Clin Exp Immunol 2002; 127:206-13.
28. Laichalk LL, Danforth JM, Standiford TJ. Interleukin-18 inhibits neutrophile phagocytotic and bactericidal activity. FEMS Immunol Med Microbiol 1996; 15:181-7.
29. Cain JA, Newman SL, Ross GD. Role of complement receptor type three and serum opsonins in the neutrophil response to yeast. Compl Inflamm 1987; 4:75-86.
30. Pryzwansky KB, Wyatt T, Reed W, Ross GD. Phorbol ester induces transient focal concentrations of functional, newly expressed CR3 in neutrophils at sites of specific granule exocytosis. Eur J Cell Biol 1991; 54:61-75.
31. Coxon A, Rieu P, Barkalow FJ et al. A novel role for the beta 2 integrin CD11b/CD18 in neutrophil apoptosis: a homeostatic mechanism in inflammation. Immunity 1996; 5:653-66.
32. Haslett C. Granulocyte apoptosis and its role in the resolution and control of lung inflammation. Am J Respir Crit Care Med 1999; 160:55-11.
33. Russell KJ, McRedmond J, Mukherji N et al. Neutrophil adhesion molecule surface expression and responsiveness in cystic fibrosis. Am J Respir Crit Care Med 1998; 157:756-61.
34. Berger M, Sorensen RU, Tosi MF, Dearborn DG, Doring G. Complement receptor expression on neutrophils at an inflammatory site, the Pseudomonas-infected lung in cystic fibrosis. J Clin Invest 1989; 84:1302-13.
35. Borregaard N, Kjeldsen L, Sengelov H et al. Changes in subcellular localization and surface expression of 1-selectin, alkaline phosphatase, and Mac-1 in human neutrophils during stimulation with inflammatory mediators. J Leukoc Biol 1994; 56:1994.
36. Sengelov H, Kjeldsen L, Diamond MS, Springer TA, Borregaard N. Subcellular localization and dynamics of Mac-1 (alpha m beta 2) in human neutrophils. J Clin Invest 1993; 92:1467-76.
37. Lord BI. Myeloid cell kinetics in response to haemopoietic growth factors. Baillieres Clin Haematol 1992; 5:533-50.
38. Lawrence E, Van Eeden S, English D, Hogg JC. Polymorphonuclear leukocyte (PMN) migration in streptococcal pneumonia: comparison of older PMN with those recently released from the marrow. Am J Respir Cell Mol Biol 1996; 14:217-24.
39. van Eeden SF, Kitagawa Y, Klut ME, Lawrence E, Hogg JC. Polymorphonuclear leukocytes released from the bone marrow preferentially sequester in lung microvessels. Microcirculation 1997; 4:369-80.
40. Van Eeden SF, Bicknell S, Walker BA, Hogg JC. Polymorphonuclear leukocytes 1-selectin expression decreases as they age in circulation. Am J Physiol 1997; 272:H401-18.
41. Wolpe SD, Sherry B, Juers D, Davatalis G, Yurt RW, Cerami A. Identification and characterization of macrophage inflammatory protein-2. Proc Natl Acad Sci USA 1989; 86:612-6.
42. Huang S, Paulauskis JD, Godleskis JJ, Kobzik L. Expression of macrophage inflammatory protein-2 and KC mRNA in pulmonary inflammation. Am J Pathol 1992; 141:981-8.
43. Driscoll KE, Hassenbein DG, Carter J et al. Macrophage inflammatory proteins 1 and 2. expression by rat alveolar macrophages, fibroblasts, and epithelial cells and in rat lung after mineral dust exposure. Am J Resp Cell Mol Biol 1993; 8:311-28.
44. Kunkel SL, Lukacs N, Kasama T, Strieter RM. The role of chemokines in inflammatory joint disease. J Leukoc Biol 1996; 59:6-12.
45. Makita H, Nishimura M, Miyamoto K et al. Effect of anti-macrophage migration inhibitory factor antibody on lipopolysaccharide-induced pulmonary neutrophil accumulation. Am J Respir Crit Care Med 1998; 158:573-9.
46. Blackwell TS, Lancaster LH, Blackwell TR, Venkatakrishnan A, Christman JW. Chemotactic gradients predict neutrophilic alveolitis in endotoxin-treated rats. Am J Respir Crit Care Med 1999; 159:1644-52.
47. Schuster A, Haarmann A, Wahn V. Cytokines in neutrophile airway inflammation in patients with cystic fibrosis. Eur Arch Otorhinolaryngol 1995; Suppl. 1:S59-S60.
48. Nagata S, Tsuchiya M, Asano S et al. Molecular cloning and expression of cDNA for human granulocyte colony-stimulating factor. Nature 1986; 319:415-8.
49. Terashima T, Kanazawa M, Sayama K et al. Granulocyte colony-stimulating factor exacerbates acute lung injury induced by intratracheal endotoxin in guinea pigs. Am J Respir Crit Care Med 1994; 149:1295-303.
50. Muhlebach MS, Stewart PW, Leigh MW, Noah TL. Quantitaion of inflammatory responses to bacteria in young cystic fibrosis and control patients. Am J Respir Crit Care Med 1999; 160:186-91.
51. Inano H, Kameyama S, Yasui S, Nagai A. Granulocyte colony-stimulating factor induces neutrophil sequestration in rabbits lungs. Am J Respir Cell Mol Biol 1998; 19:167-74.
52. Hierholzer C, Kelly E, Lyons V et al. G-CSF instillation into rat lungs mediates neutrophil recruitment, pulmonary edema, and hypoxia. J Leukoc Biol 1998; 63:169-74.
53. Meng ZH, Dyer K, Billiar TR, Tweardy DJ. Distinct effects of systemic infusion of G-CSF vs. IL-6 on lung and liver inflammation and injury in hemorrhagic shock. Shock 2000; 14:41-8.
54. Jilma B, Hergovich N, Homoncik M, Marsik C, Kreuzer C, Jilma-Stohlawetz P. Rapid down modulation of P-selectin glycoprotein ligand-1 (PSGL-1, CD162) by G-CSF in humans. Transfusion 2002; 42:328-33.
55. Borregaard N, Cowland JB. Granules of the human neutrophilic polymorphonuclear leukocyte. Blood 1997; 89:3503-21.
56. Smith WB, Gamble JR, Vadas MA. The role of granulocyte-macrophage and granulocyte colony-stimulating factors in neutrophil transendothelial migration: comparison with interleukin-8. Exp Hematol 1994; 22:329-34.
57. Xing Z, Jordana M, Kirpalani H, Driscoll KE, Schall TJ, Gauldie J. Cytokine expression by neuthrophils and macrophages in vivo, endotoxin induces tumor necrosis factor, macrophage inflammatory Protein-2, interleukin-1 and interleukin-6, but not RANTES or transforming growth factor BETA mRNAs expression in acute lung inflammation. Am J Respir Cell Mol Biol 1994; 18:148-53.
58. Bonfield TL, Panuska JR, Konstan MW et al. Inflammatory cytokines in cystic fibrosis lungs. Am J Respir Crit Care Med 1995; 152:2111-18.
59. Francoeur C, Denis M. Nitric oxide and interleukin-8 as inflammatory components of cystic fibrosis. Inflammation 1995; 19:587-98.
60. Laterveer L, Lindley IJ, Heemskerk DP et al. Rapid mobilization of hematopoietic progenitor cells in rhesus monkeys by a single intravenous injection of interleukin-8. Blood 1996; 87:781-8.
61. Broxmeyer HE, Sherry B, Cooper S et al. Comparative analysis of the human macrophage inflammatory protein family of cytokines (chemokines) on proliferation of human myeloid progenitor cells. Interacting effects involving suppression, synergistic suppression, and blocking of suppression. J Immunol 1993; 150:3448-58.
62. Cacalano G, Lee J, Kikly K et al. Neutrophil and B cell expansion in mice that lack the murine IL-8 receptor homolog. Science 1994; 265:682-4.
63. Nomura H, Imazeki I, Oheda M et al. Purification and characterization of human granulocyte colony-stimulating factor (G-CSF). EMBO J 1986; 5:871-6.
64. Uchida T, Yamagiwa A. Kinetics of rG-CSF-induced neutrophilia in mice. Exp Hematol 1992; 20:152-5.
65. Schmitz S, Franke H, Brusis J, Wichmann HE. Quantification of the cell kinetic effects of G-CSF using a model of human granulopoiesis. Exp Hematol 1993; 21:755-60.